Wedad M.Nageeb

Dr. Wedad M.Nageeb

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WMWedad M.Nageeb
Wedad M.Nageeb
HHHelal F. Hetta
Helal F. Hetta
Informed antibiotic prescription offers a practical solution to antibiotic resistance problem. With the increasing affordability of different sequencing technologies, molecular-based resistance prediction would direct proper antibiotic selection and preserve available agents. Amikacin is a broad-spectrum aminoglycoside exhibiting higher clinical efficacy and less resistance rates inPs.aeruginosadue to its structural nature and its ability to achieve higher serum concentrations at lower therapeutic doses. This study examines the predictive potential of molecular markers underlying amikacin susceptibility phenotypes in order to provide improved diagnostic panels. Using a predictive model, genes and variants underlying amikacin resistance have been statistically and functionally explored in a large comprehensive and diverse set ofPs.aeruginosacompletely sequenced genomes. Different genes and variants have been examined for their predictive potential and functional correlation to amikacin susceptibility phenotypes. Three predictive sets of molecular markers have been identified and can be used in a complementary manner, offering promising molecular diagnostics.armR,nalC,nalD,mexR,mexZ,ampR,rmtD,nalDSer32Asn,fusA1Y552C,fusA1D588G,arnAA170T, andarnDG206C have been identified as the best amikacin resistance predictors inPs.aeruginosawhilefaoAT385A,nuoGA890T,nuoGA574T,lptAT55A,lptAR62S,pstBR87C,gidBE126G,gidBQ28K,amgSE108Q, andrplYQ41L have been identified as the best amikacin susceptibility predictors. Combining different measures of predictive performance together with further functional analysis can help design new and more informative molecular diagnostic panels. This would greatly inform and direct point of care diagnosis and prescription, which would consequently preserve amikacin functionality and usefulness.

1 January 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
WMWedad M.Nageeb
Wedad M.Nageeb
Dina AminDina Amin
Dina Amin
ZMZuhair M. Mohammedsaleh
Zuhair M. Mohammedsaleh
RMRabab Makharita
Rabab Makharita
The population structure of Pseudomonas aeruginosa is panmictic-epidemic in nature, with the prevalence of some high-risk clones. These clones are often linked to virulence, antibiotic resistance, and more morbidity. The clonal success of these lineages has been linked to acquisition and spread of mobile genetic elements. The main aim of the study was to explore other molecular markers that explain their global success. A comprehensive set of 528 completely sequenced P. aeruginosa genomes was analyzed. The population structure was examined using Multilocus Sequence Typing (MLST). Strain relationships analysis and diversity analysis were performed using the geoBURST Full Minimum Spanning Tree (MST) algorithm and hierarchical clustering. A phylogenetic tree was constructed using the Unweighted Pair Group Method with Arithmetic mean (UPGMA) algorithm. A panel of previously investigated resistance markers were examined for their link to high-risk clones. A novel panel of molecular markers has been identified in relation to risky clones including armR, ampR, nalC, nalD, mexZ, mexS, gyrAT83I, gyrAD87N, nalCE153Q, nalCS46A, parCS87W, parCS87L, ampRG283E, ampRM288R, pmrALeu71Arg, pmrBGly423Cys, nuoGA890T, pstBE89Q, phoQY85F, arnAA170T, arnDG206C, and gidBE186A. In addition to mobile genetic elements, chromosomal variants in membrane proteins and efflux pump regulators can play an important role in the success of high-risk clones. Finding risk-associated markers during molecular surveillance necessitates applying more infection-control precautions.

22 October 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Helal HettaHelal Hetta
Helal Hetta
ZRZeinab Rashed
Zeinab Rashed
YRYasmin Nasr Ramadan
Yasmin Nasr Ramadan
Israa M.S. Al-KadmyIsraa M.S. Al-Kadmy
Israa M.S. Al-Kadmy
SKSoheir M. Kassem
Soheir M. Kassem
WMWedad M.Nageeb
Wedad M.Nageeb
Infective endocarditis (IE) is defined as an infection of the endocardium, or inner surface of the heart, most frequently affecting the heart valves or implanted cardiac devices. Despite its rarity, it has a high rate of morbidity and mortality. IE generally occurs when bacteria, fungi, or other germs from another part of the body, such as the mouth, spread through the bloodstream and attach to damaged areas in the heart. The epidemiology of IE has changed as a consequence of aging and the usage of implantable cardiac devices and heart valves. The right therapeutic routes must be assessed to lower complication and fatality rates, so this requires early clinical suspicion and a fast diagnosis. It is urgently necessary to create new and efficient medicines to combat multidrug-resistant bacterial (MDR) infections because of the increasing threat of antibiotic resistance on a worldwide scale. MDR bacteria that cause IE can be treated using phages rather than antibiotics to combat MDR bacterial strains. This review will illustrate how phage therapy began and how it is considered a powerful potential candidate for the treatment of MDR bacteria that cause IE. Furthermore, it gives a brief about all reported clinical trials that demonstrated the promising effect of phage therapy in combating resistant bacterial strains that cause IE and how it will become a hope in future medicine.

8 September 2023 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
WMWedad M.Nageeb
Wedad M.Nageeb
Helal HettaHelal Hetta
Helal Hetta
Background: Over the past two decades, Corynebacterium striatum has been increasingly isolated from clinical cultures with most isolates showing increased antimicrobial resistance (AMR) to last resort agents. Advances in the field of pan genomics would facilitate the understanding of the clinical significance of such bacterial species previously thought to be among commensals paving the way for identifying new drug targets and control strategies. Methods: We constructed a pan-genome using 310 genome sequences of C. striatum. Pan-genome analysis was performed using three tools including Roary, PIRATE, and PEPPAN. AMR genes and virulence factors have been studied in relation to core genome phylogeny. Genomic Islands (GIs), Integrons, and Prophage regions have been explored in detail. Results: The pan-genome ranges between a total of 5253–5857 genes with 2070 − 1899 core gene clusters. Some antimicrobial resistance genes have been identified in the core genome portion, but most of them were located in the dispensable genome. In addition, some well-known virulence factors described in pathogenic Corynebacterium species were located in the dispensable genome. A total of 115 phage species have been identified with only 44 intact prophage regions. Conclusion: This study presents a detailed comparative pangenome report of C. striatum. The species show a very slowly growing pangenome with relatively high number of genes in the core genome contributing to lower genomic variation. Prophage elements carrying AMR and virulence elements appear to be infrequent in the species. GIs appear to offer a prominent role in mobilizing antibiotic resistance genes in the species and integrons occur at a frequency of 50% in the species. Control strategies should be directed against virulence and resistance determinants carried on the core genome and those frequently occurring in the accessory genome.

14 August 2025 in Journal of Chemotherapy
Verified
Journal Article
Closed access
Ahmed ElfadadnyAhmed Elfadadny
Ahmed Elfadadny
RRRokaia F. Ragab
Rokaia F. Ragab
OAOsama Aldesoky Abd Alaziz
Osama Aldesoky Abd Alaziz
HEHabiba Y. Essa
Habiba Y. Essa
EEEsraa M. Eltony
Esraa M. Eltony
WMWedad M.Nageeb
Wedad M.Nageeb
The increasing prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa infections poses a major challenge in clinical settings, particularly when antibiotic therapy fails and surgical source control is not feasible. Bacteriophage therapy (BT) has emerged as a promising alternative, offering a targeted approach to combat persistent infections. Recent advancements in phage isolation, purification and genomic characterization have facilitated their use in compassionate treatment cases. Studies suggest that phage-antibiotic synergy can enhance bacterial eradication while potentially mitigating resistance development. However, challenges remain regarding optimal dosing strategies, host immune responses and regulatory approval pathways. This review examines the current state of BT for P. aeruginosa infections, its mechanisms of action, clinical applications and future directions for integrating phage-based treatments into infectious disease management.

2 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WMWedad M.Nageeb
Wedad M.Nageeb
SASherouk Hussein Adam
Sherouk Hussein Adam
NHNasr Hashem
Nasr Hashem
NANelly Abdelsalam
Nelly Abdelsalam
Different Streptococcal species including Streptococcus mutans, Streptococcus sobrinus and Enterococcus faecalis are commonly isolated in root canal infections including refractory, recurrent, and persistent cases. Calcium hydroxide (Ca (OH)2) has been widely used in endodontics as an intracanal medicament. However, using new antimicrobial herbal alternatives offers promising potentials which can be additionally enhanced by using nanoparticles (NPs). In this study, we evaluate the antimicrobial efficacy and antibiofilm effect of Neem oil including its NPs preparations and we compare the effect of conventional Ca (OH)2 to Ca (OH)2 NPs using standard disc diffusion method and quantitative microtitre dish biofilm formation assay against common pathogens isolated from root canal samples. Molecular docking was used to test the binding of 10 Streptococcal macromolecules to 5 candidate neem active constituents. Neem NPs 0.125 mg/ml showed better antibacterial effect than both Neem 15 mg/ml and Neem 0.15 mg/ml. Ca (OH)2 NPs 0.125 mg/ml also showed better antibacterial effect than each of Ca (OH)2 10 mg/ml and Ca (OH)2 0.1 mg/ml. Best biofilm mass inhibition was achieved by Neem oil 0.15 mg/ml at 74.55% ( IQ: 67.36–87.65) and Neem NPs 0.0125 mg/ml at 59.33% (IQ: 51-–75.27). For Ca (OH)2, the best biofilm mass inhibition was observed with Ca (OH)2 NPs 0.125 mg/ml at 54.7% (IQ: 42.37– 77.25). Both neem oil and neem NPs show promising antibacterial and antibiofilm potential against Mutans Streptococci group at low concentrations and hence are good candidates for use as endodontic medications. In silico analysis shows that both Sitosterol and Gedunin appear to be important active constituents of neem and possible drug candidates. Additionally, Ca (OH)2 NPs showed significantly higher antimicrobial effect against Mutans streptococci group than conventional Ca (OH)2 preparations.